References
- Rock J, Garcia CR. Observed effects of 19-nor steroids on ovulation and menstruation. In Proceedings of a Symposium on 19-nor progestational steroids. Chicago: Searle Research Laboratories, 1957:14–31.
- Pincus G, Rock J, Garcia CR, et al Fertility control with oral medication. Am J Obstet Gynecol 1958;75:1333–1346.
- Junod SW, Marks L. Women's trials: The approval of the first oral contraceptive pill in the United States and Great Britain. J Hist Med Allied Sci 2002;57:117–160.
- Jordan WM. Pulmonary embolism. Lancet 1961;ii:1146–1147.
- Astedt B, Jeppsson S, Liedholm P, et al Clinical trial of a new oral contraceptive pill containing the natural oestrogen 17 beta-oestradiol. Br J Obstet Gynaecol 1979;86:732–736.
- Csemiczky G, Dieben T, Coeling Bennink HJ, Landgren BM. The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17β-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg desogestrel only for 7 days. Contraception 1996;54:333–338.
- Hoffmann H, Moore C, Zimmermann H, et al Approaches to the replacement of ethinylestradiol by natural 17beta-estradiol in combined oral contraceptives. Exp Toxicol Pathol 1998;50:458–464.
- Serfaty D, Christin-Maitre S, Ochsenbein E, Thomas JL. Comparison of two regimens of new monophasic oral contraceptive combining 17 beta-estradiol and nomegestrol acetate. Poster presented at the XIXth FIGO World Congress of Gynecology and Obstetrics, 4–9 October, 2009, Cape Town, South Africa.
- Endrikat J, Parke S, Trummer D, et al Ovulation inhibition with four variations of a four phasic esradiol valerate/ dienogest combined oral contraceptive. Contraception 2008;78:218–225.
- Zeun S, Lu M, Uddin A, et al Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest. Eur J Contracept Reprod Health Care 2009;14:221–232.